瘤发病和细胞信号通路的IGFBP3调节 (综述)
Yanzi Zhang1,2, Xin Lv1,2
1Clinical Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, Shandong 250022, P.R. China.
Oncology letters
|June 12, 2025
概括
胰岛素样生长因子结合蛋白3 (IGFBP3) 水平在瘤中发生变化. 了解这些IGFBP3变化和相关的细胞信号通路可以指导精确的瘤治疗.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 胰岛素样生长因子结合蛋白3 (IGFBP3) 是循环胰岛素样生长因子的主要载体.
- 在高亲和度IGF结合蛋白中,IGFBP3是最受研究的.
- 异常的IGFBP3表达与瘤的发展和进展有关.
研究的目的:
- 在各种瘤中审查IGFBP3表达水平的变化.
- 探索IGFBP3,细胞信号通路和瘤行为之间的关系.
- 为精确的瘤治疗策略提供见解.
主要方法:
- 对瘤IGFBP3表达研究的文献综述.
- 分析IGFBP3变化与细胞信号通路之间的联系.
- IGFBP3变化与细胞生物行为的相关性.
主要成果:
- 在瘤中的转录和后翻译水平上记录了IGFBP3表达的改变.
- 确定了IGFBP3和关键细胞信号通路 (例如IGF,Wnt,TGF-β) 之间的关联.
- 观察IGFBP3调节对瘤细胞增殖,细胞亡,迁移和入侵的影响.
结论:
- IGFBP3在瘤生物学中起着重要作用.
- 改变IGFBP3表达是瘤进展的潜在生物标志物.
- 向IGFBP3及其相关途径可能为癌症提供新的治疗策略.
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Activation of Integrins
3.3K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


